Raymond James Financial’s Evolv Technologies EVLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.73M Buy
450,658
+26,030
+6% +$152K ﹤0.01% 3100
2025
Q4
$3.04M Buy
424,628
+33,516
+9% +$238K ﹤0.01% 2919
2025
Q3
$2.95M Buy
391,112
+92,823
+31% +$678K ﹤0.01% 2875
2025
Q2
$1.86M Buy
298,289
+276,644
+1,278% +$1.28M ﹤0.01% 3133
2025
Q1
$67.5K Buy
21,645
+326
+2% +$1.14K ﹤0.01% 4608
2024
Q4
$84.2K Buy
+21,319
New +$74.8K ﹤0.01% 4549

Other funds holding EVLV

Raymond James Financial's EVLV Position: Q1 2026 in Review

Raymond James Financial increased its Evolv Technologies (EVLV) stake by 6.1% in Q1 2026, buying an estimated $152K and bringing the position to 450,658 shares worth $2.73M. The position accounts for ﹤0.01% of the portfolio, ranked #3100.

Raymond James Financial first reported a position in EVLV in Q4 2024 and has held it in 6 quarters since. The position peaked at $3.04M in Q4 2025. 260 funds tracked by Wall St. Rank hold EVLV as of Q1 2026.

  • Raymond James Financial held 450,658 shares of Evolv Technologies worth $2.73M as of Q1 2026.
  • Raymond James Financial bought 26,030 Evolv Technologies shares in Q1 2026, an estimated $152K.
  • Evolv Technologies made up ﹤0.01% of Raymond James Financial's portfolio in Q1 2026, its #3100 holding.
  • Raymond James Financial first reported a position in Evolv Technologies in Q4 2024 and has held it in 6 quarters since.
  • Raymond James Financial's Evolv Technologies position peaked at $3.04M in Q4 2025.
  • 260 funds tracked by Wall St. Rank held Evolv Technologies as of Q1 2026.

Based on Raymond James Financial's 13F filing for Q1 2026, filed 14 May 2026.